Prevalence of atherogenic dyslipidemia: Association with risk factors and cardiovascular risk in Spanish working population. "ICARIA" study

Atherosclerosis

Volumn 235, Issue 2, 2014, Pages 562-569

  Cabrera, M ^a   Sanchez Chaparro M A ^b   Valdivielso, P ^b   Quevedo Aguado, L ^a   Catalina Romero, C ^a   Fernandez Labandera C ^a   Ruiz Moraga, M ^a   Gonzalez Santos P ^b   Calvo Bonacho, E ^a  

^a Ibermutuamur ^*  (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

Atherogenic dyslipidemia; Cardiovascular risk; HDL; Triglycerides

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; URIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ATHEROGENIC DYSLIPIDEMIA; CARDIOVASCULAR RISK; DIABETES MELLITUS; DYSLIPIDEMIA; EMPLOYEE; FEMALE; HUMAN; HYPERTENSION; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SPANIARD; ADVERSE EFFECTS; ATHEROSCLEROSIS; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; CROSS-SECTIONAL STUDY; DYSLIPIDEMIAS; MIDDLE AGED; SPAIN;

ADULT; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; SMOKING; SPAIN; TRIGLYCERIDES;

EID: 84920648093     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.05.960     Document Type: Article

References (46)

1. Bansal S., Buring J.E., Rifai N., et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAm Med Assoc 2007, 298:309-316.
2. González Santos P. Dislipemia aterogénica. Clínica e Investigación en Arteriosclerosis 2012, 24(Suppl.1):3-7.
3. Nordestgaard B.G., Benn M., Schnohr P., et al. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAm Med Assoc 2007, 298:299-308.
4. Grundy S.M. Atherogenic dyslipidemia: lipoprotein abnormalities and implications for therapy. Am J Cardiol 1995, 75:45B-52B.
5. Austin M.A., King M.C., Vranizan K.M., et al. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 1990, 82:495-506.
6. Chapman M.J., Ginsberg H.N., Amarenco P., et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J 2011, 32:1345-1361.
7. Arca M., Montali A., Valiante S., et al. Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease. Am J Cardiol 2007, 100:1511-1516.
8. Reiner Z. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update. Nutr Metab Cardiovasc Dis 2013, 23:799-807.
9. Millan J., Pedro-Botet J., Pinto X., et al. Emerging risk factors related to residual risk. Med Clin (Barc) Spain 2011, 92-93.
10. Fruchart J.C., Sacks F., Hermans M.P., et al. The residual risk reduction initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia. Am J Cardiol 2008, 102:1k-34k.
11. Laforest L., Ambegaonkar B.M., Souchet T., et al. Mixed dyslipidemias in primary care patients in France. Vasc Health Risk Manag 2012, 8:247-254.
12. Alsheikh-Ali A.A., Lin J.L., Abourjaily P., et al. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol. Am J Cardiol 2007, 100:1499-1501.
13. Ninomiya J.K., L'Italien G., Criqui M.H., et al. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004, 109:42-46.
14. Karalis D.G. Intensive lowering of low-density lipoprotein cholesterol levels for primary prevention of coronary artery disease. Mayo Clin Proc 2009, 84:345-352.
15. Sanchez-Chaparro M.A., Roman-Garcia J., Calvo-Bonacho E., et al. Prevalence of cardiovascular risk factors in the Spanish working population. Rev Esp Cardiol 2006, 59:421-430.
16. Sanchez-Chaparro M.-A., Calvo-Bonacho E., Gonzalez-Quintela A., et al. Occupation-Related differences in the prevalence of metabolic syndrome. Diabetes Care 2008, 31:1884-1885.
17. Valdivielso P., Sanchez-Chaparro M.A., Calvo-Bonacho E., et al. Association of moderate and severe hypertriglyceridemia with obesity, diabetes mellitus and vascular disease in the Spanish working population: results of the ICARIA study. Atherosclerosis 2009, 207:573-578.
18. Sierra M.C., Bonacho E.C., Garcia A.G., et al. Effectiveness of a preventive intervention strategy based on structured telephone interviews in a working population with a moderate to high cardiovascular risk. Aten Primaria 2010, 42:498-505.
19. Reiner Z., Catapano A.L., De Backer G., et al. ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011, 32:1769-1818.
20. Perk J., De Backer G., Gohlke H., et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012, 33:1635-1701.
21. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
22. Conroy R.M., Pyorala K., Fitzgerald A.P., et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003, 24:987-1003.
23. Graham I., Atar D., Borch-Johnsen K., Boysen G., et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary: fourth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2007, 28:2375-2414.
24. Sanchez Chaparro M.A., Calvo Bonacho E., Gonzalez Quintela A., et al. High cardiovascular risk in Spanish workers. Nutr Metab Cardiovasc Dis 2011, 21:231-236.
25. Caballero Sarmiento R. Epidemiology of atherogenic dyslipidemia in an urban area of the city of Barcelona. Clin Investig Arterioscler 2014, 26:17-19.
26. Banegas Banegas J.R., Villar Alvarez F., Perez de Andres C., et al. An epidemiological study on cardiovascular risk factors in 35-64 years old Spanish population. Rev Sanid Hig Publica (Madr) 1993, 67:419-445.
27. Villar-Alvarez F., Banegas-Banegas J.R., de Mata-Donado Campos J., et al. Las enfermedades cardiovasculares y sus factores de riesgo en España: hechos y cifras. Informe SEA 2007 2007, Visto Bueno Equipo Creativo, S.L, Madrid.
28. Cordero A., Leon M., Andres E., et al. Gender differences in obesity related cardiovascular risk factors in Spain. Prev Med 2009, 48:134-139.
29. Valles M., Mate G., Bronsoms J., et al. Prevalence of arterial hypertension and other cardiovascular risk factors among hospital workers. Med Clin (Barc) 1997, 108:604-607.
30. Vicente D., Martinez S., Gil V., et al. Cardiovascular risk factors in the working population of Alicante. Aten Primaria 1991, 8:477-478. 480-472.
31. Kannel W.B. Lipids, diabetes, and coronary heart disease: insights from the Framingham study. Am Heart J 1985, 110:1100-1107.
32. U.K.Prospective Diabetes Study 27 Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex. Diabetes Care 1997, 20:1683-1687.
33. Chelland Campbell S., Moffatt R.J., Stamford B.A. Smoking and smoking cessation - the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis 2008, 201:225-235.
34. Despres J.P., Lamarche B., Mauriege P., et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. NEngl J Med 1996, 334:952-957.
35. Pyorala M., Miettinen H., Laakso M., et al. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen study. Circulation 1998, 98:398-404.
36. Grundy S.M. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 2002, 105:2696-2698.
37. Pascot A., Lemieux I., Prud'homme D., et al. Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. JLipid Res 2001, 42:2007-2014.
38. Lippi G., Montagnana M., Franchini M., et al. The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta 2008, 392:1-7.
39. Brinton E.A. Effects of ethanol intake on lipoproteins and atherosclerosis. Curr Opin Lipidol 2010, 21:346-351.
40. Pinto X., Valdivielso P., Perez de Juan J.M., et al. Predictive factors of achieving therapeutic goals of hypertriglyceridemia. Curr Med Res Opin 2014, 30:19-26.
41. Volcik K., Ballantyne C.M., Pownall H.J., et al. Interaction effects of high-density lipoprotein metabolism gene variation and alcohol consumption on coronary heart disease risk: the atherosclerosis risk in communities study. JStud Alcohol Drugs 2007, 68:485-492.
42. Ariza M.J., Sanchez-Chaparro M.A., Baron F.J., et al. Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study. BMC Med Genet 2010, 11:66.
43. Wang J., Ban M.R., Zou G.Y., et al. Polygenic determinants of severe hypertriglyceridemia. Hum Mol Genet. 2008, 17:2894-2899.
44. Wakabayashi I. Alcohol intake and triglycerides/high-density lipoprotein cholesterol ratio in men with hypertension. Am J Hypertens 2013, 26:888-895.
45. Wakabayashi I. Relationships between alcohol intake and atherogenic indices in women. JClin Lipidol 2013, 7:454-462.
46. Calvo-Bonacho E., Ruilope L.M., Sanchez-Chaparro M.A., et al. Influence of high cardiovascular risk in asymptomatic people on the duration and cost of sick leave: results of the ICARIA study. Eur Heart J 2014, 35:299-306.